sensory innervation of head and neck figures 6 2 and 6 3b table 6 3

Tài liệu Diagnosis and management of head and neck cancer docx

... centre .2 36 The five-year local control rate for patients following interstitial brachytherapy for T3 oral cavity tumours is 49-70% . 23 2 ,2 36 , 23 7 , 23 9 A dose of 65 Gy results in optimal local control . 23 3 ... reduction of death after concurrent chemotherapy by age314 ,31 5 Age Percentage reduction in risk of death 60 or less 22 -24 % 60 -70 12% over 70 3% 25 diagnosis and management of head and neck cancer ... fractions ( 62 Gy-2Gy per fraction equivalent) is required .3 06 1++ A dose of 54 -60 Gy in 27 -30 fractions, five days per week to the primary site and nodes at risk with boost to 66 Gy in 33 fractions in 6. 5...

96
554
0

Pocket Guide To TNM STAGING OF HEAD AND NECK CANCER AND NECK DISSECTION CLASSIFICATION pdf

Danh mục: Sức khỏe giới tính

... Staging—classification—Handbooks WE 39 P 739 20 08] RC280.N35P 63 20 08 61 6.99'491—dc 22 2008 022 33 1 AMERICAN ACADEMY OF OTOLARYNGOLOGY– HEAD AND NECK SURGERY HEAD AND NECK SURGERY COMMITTEE FACULTY DEVRAJ ... Stage IVA Stage IVB Stage IVC Tis T1 T2a T1 T2 T2a T2b T2b T1 T2a T2b T3 T3 T3 T4 T4 T4 Any T Any T N0 N0 N0 N1 N1 N1 N0 N1 N2 N2 N2 N0 N1 N2 N0 N1 N2 N3 Any N M0 M0 M0 M0 M0 M0 M0 M0 M0 M0 M0 ... Guide to NECK DISSECTION CLASSIFICATION AND TNM STAGING OF HEAD AND NECK CANCER Committee for Head and Neck Surgery and Oncology American Academy of Otolaryngology– Head and Neck Surgery Neck Dissection...

30
940
0

DIAGNOSIS AND MANAGEMENT OF HEAD AND NECK CANCER pptx

Danh mục: Sức khỏe giới tính

... mucosal surface of the lip DIAGRAM OF THE HEAD AND NECK Oral cavity Oropharynx Larynx Hypopharynx ALL HEAD AND NECK CANCERS DIAGRAM OF THE LYMPH NODES LEVELS IN THE NECK I II III VI IV V NECK DISSECTION ... within two weeks of urgent referral DIAGNOSIS AND STAGING D Fine needle aspiration cytology should be used in the investigation of head and neck masses D All patients with head and neck cancer should ... areas of metastatic disease in patients with head and neck cancer should include: number of involved nodes level of involved nodes extracapsular spread of tumour type of nodal dissection size of...

16
418
0

Báo cáo sinh học: "High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area" pdf

Danh mục: Hóa học - Dầu khí

... (33 .3% ) (66 .7%) Yes 48 (84 .2% ) 28 (58 .3% ) 20 (41.7%) 1.77 (010, 30 . 72) 0 .69 5 Betel nuts Never 20 (35 .1%) (40.0%) 12 (60 .0%) Yes 37 (64 .9%) 23 ( 62 .2% ) 14 (37 .8%) 0.109 12. 78 (1 .28 - 127 . 62 ) 0. 030 * ... 12 81.8% 0. 035 * 83. 3% Stage IVa 10 80.0% 0.119 90.0% IVb 47 57 .2% 0 -2 66 .7% 3- 4 51 60 .5% 12 50.0% 45 57 .3% 60 00 cGy 20 55.0% > 60 00 cGy 37 64 .5% never 11 63 .6% yes 46 60 .6% 48 66 .7% 60 .1% 0 .61 4 ... (21 .1%) (41.7%) (58 .3% ) positive 45 (78.9%) 26 (57.8%) 19 ( 42. 2%) 0.5 03 11 (17 .2% ) 46 ( 82. 8%) ( 36 . 4%) 27 (58.7%) ( 63 .6% ) 19 (41 .3% ) 0 .31 8 0 .27 5 0.75 (0.15, 3 .64 ) 0. 727 2. 49 (0 .31 , 19.88) 0 .38 8...

8
689
0

báo cáo hóa học:" High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area" pdf

Danh mục: Hóa học - Dầu khí

... (33 .3% ) (66 .7%) Yes 48 (84 .2% ) 28 (58 .3% ) 20 (41.7%) 1.77 (010, 30 . 72) 0 .69 5 Betel nuts Never 20 (35 .1%) (40.0%) 12 (60 .0%) Yes 37 (64 .9%) 23 ( 62 .2% ) 14 (37 .8%) 0.109 12. 78 (1 .28 - 127 . 62 ) 0. 030 * ... 12 81.8% 0. 035 * 83. 3% Stage IVa 10 80.0% 0.119 90.0% IVb 47 57 .2% 0 -2 66 .7% 3- 4 51 60 .5% 12 50.0% 45 57 .3% 60 00 cGy 20 55.0% > 60 00 cGy 37 64 .5% never 11 63 .6% yes 46 60 .6% 48 66 .7% 60 .1% 0 .61 4 ... (21 .1%) (41.7%) (58 .3% ) positive 45 (78.9%) 26 (57.8%) 19 ( 42. 2%) 0.5 03 11 (17 .2% ) 46 ( 82. 8%) ( 36 . 4%) 27 (58.7%) ( 63 .6% ) 19 (41 .3% ) 0 .31 8 0 .27 5 0.75 (0.15, 3 .64 ) 0. 727 2. 49 (0 .31 , 19.88) 0 .38 8...

8
428
0

Báo cáo khoa học: "Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy" pdf

Danh mục: Báo cáo khoa học

... report of RTOG 961 0, a multiinstitutional trial ofreirradiation and chemotherapy for unresectable 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 recurrent squamous cell carcinoma of the head and neck ... compared 43 cases of 12. 5 Gy SRS and 43 cases of 34 Gy delivered in 2 -6 fractions of SRT The 1- and 3- year local failure-free survival rates were 70% and 51% for the SRS group and 91% and 83% for ... matched-cohort analysis Head Neck Oncol 20 09, 23 ;1: 13 41 Wang CC, McIntyre J: Reirradiation of laryngeal carcinoma: Techniques and results Int J Radiat Oncol Biol Phys 19 93, 26 : 7 83- 785 42 Tselis N, Ratka...

10
523
0

Báo cáo khoa học: "FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma" pps

Danh mục: Báo cáo khoa học

... 17.7 65 .9 16. 1 52. 5 5.4 45.5 8.7 35 .3 6. 3 17.4 2. 1 9.8 37 .0 6. 0 28 .9 6. 5 13. 4 1 .3 17.8 40.8 7.1 19.5 30 .3 49.0 22 .2 34 .1 1.7 46. 3 12. 1 20 .1 3. 5 8.0 4.5 1.7 57.8 2 .6 11 .2 17 .3 4.7 4.0 15 .2 34 .7 ... 11 .2 17 .3 4.7 4.0 15 .2 34 .7 8.9 6. 5 36 . 5 78.7 25 .1 60 .2 5.4 64 .2 13. 5 36 . 1 6. 4 17.8 5 .3 9.8 60 .3 6. 2 29.4 19.8 13. 9 5.0 20 .3 61 .8 11.9 19.5 Discussion The use of FDG-PET/CT prior to treatment ... II IIB III IVA IVB Pathologic TNM categories T1, T2, T2b, T3, T4a N0 M0 T2, T4a N1 M0 T2 N2a M0 T2, T3, T4a N2b M0 T4 N3 M0 22 59 43 76 18 6 18 13 Abbreviations: AJCC: American Joint Committee...

6
571
0

Báo cáo khoa học: " Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy" ppsx

Danh mục: Báo cáo khoa học

... Total 21 45.0 14.0 30 .0 66 ,0 15 30 .0 9 .3 25 .0 50.0 21 21 .0 10 .3 7.0 42. 0 21 65 .0 11 .6 46 105.0 21 53. 1 13. 8 53. 1 86. 1 21 31 .0 17.9 13. 0 91.0 21 35 .4 10.9 29 ,5 59.0 21 111 .2 22. 2 62 .2 1 46. 8 Legend ... control % P* 15 56. 7 73. 3 0 .33 30 10 50.0 50.0 66 .7 0 .34 85 14 71.5 52. 8 0.8 920 13 63 .5 53. 8 0.94 36 16 60.0 50.0 0.4 36 5 12 6 50.0 66 .7 33 .3 0.8814 12 50.0 55.5 0.8 966 13 11 84 .6 0.0007 tion (primarily ... Chemotherapy Yes No Total n pacients % 15 71.4 28 .6 16 76. 2 23. 8 10 4.8 19.0 47 .6 28 .6 12 57.1 28 .6 14 .3 15 71.4 28 .6 01 20 4.8 95 .2 21 100 median 53. 5 Three-dimensional planning CT image reconstruction...

6
317
0

báo cáo khoa học: " Clinico-pathological profile of head and neck malignancies at University College Hospital, Ibadan, Nigeria" pdf

Danh mục: Báo cáo khoa học

... Lymphomas 25 -44 45 -64 65 TOTAL 19 (2. 2%) Carcinomas 15 -24 77(8.8%) 23 8 (27 .2% ) 36 1 (41.4%) 178 (20 .4%) 8 73* (100%) 46( 22 %) 32 ( 15 .3% ) 56( 26 . 8%) 59 (28 .2% ) 60 (28 .7%) 20 9(100%) 20 (18.9%) 34 ( 32 . 1%) 35 (33 %) ... 5(9.4%) 25 Tongue 24 (7.7%) 1(1.9%) 25 Tonsil FOM 12( 3. 9%) 11 (3. 5%) 13( 18 .6% ) 1(1.9%) 26 11 Lip Sarcomas 8 (2 .6% ) 1(1.4%) Mandible 43( 13. 9%) 26 ( 37 .1%) 16( 30 .2% ) 85 Maxilla 63 (20 .3% ) 22 (31 .4%) 20 (37 .7%) ... 8.8 Mandible Salivary glands Palate 85 60 19 .6 13. 9 7.1 5.0 55 12. 7 4 .6 Tonsil 26 6.0 2. 2 Cheek 25 5.8 2. 1 Tongue 25 5.8 2. 1 Floor of mouth 11 2. 5 0.9 Lip 2. 1 0.8 Face 32 7.4 2. 7 TOTAL 433 100...

9
195
0

Báo cáo y học: "Systems biology-defined NF-κB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status" pps

Danh mục: Báo cáo khoa học

... display and Genome Biology 20 08, 9:R 53 http://genomebiology.com /20 08/9 /3/ R 53 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Genome Biology 20 08, cDNA microarray reveals altered expression of ... SFN↓ 3. 0 × 10 -2 CYR61↓, IGFBP2↑, IGFBP3↑, IGFBP6↑, PIK3R3↑, SFN↓ M 1 .3 × 10 -3 ACTG2↓, ACTN3↓, AKT1↓, BCAR3↓, DDEF1↓, ITGA2↓, ITGA5↓, ITGB4↓, LAMA3↓, LAMB3↓, LAMC2↓, PIK3R3↑, PLCG2↑, RAC2↓, RHOA↓, ... IL1A↓, IL6↑, NOS2A↓, NQO1↑, PPARBP↓, PPP2R5B↓, PRKCQ↓, SULT1A3↑ M 8.7 × 10 -3 ALDH1A2↑, ALDH1A3↑, ALDH3B2↑, CYP1A2↑, CYP3A4↓, EIF2AK3↓, FMO3↓, IL1A↓, IL1B↓, IL6↑, NFE2L2↑, NQO1↑, PIK3R3↑, PPARBP↓,...

22
434
0

Regenerative Medicine Reconstruction of Tracheal and Pharyngeal Mucosal Defects in Head and Neck Surgery

Danh mục: Hóa học - Dầu khí

... Irish, J., and Gullane, P.J (20 03) Pharyngocutaneous ﬁstula Curr References 26 27 28 29 30 31 32 33 34 35 36 37 Opin Otolaryngol Head Neck Surg., 11, 78–84 Fung, K., Teknos, T.N., Vandenberg, ... M.T., and Birchall, M.A (20 08) Clinical transplantation of a tissue-engineered airway Lancet, 3 72 ( 965 5), 20 23 20 30 Erratum in: Lancet 20 09 Feb 7 ;37 3( 966 2) : 4 62 Ernst, A and Ashiku, S (20 06) Tracheal ... Otolaryngol Head Neck Surg., 121 , 13 56 1 36 0 59 Pietrzak, W.S., Sarver, D.R., and 60 61 62 63 64 65 66 67 68 Verstynen, B.S (1997) Bioabsorbable polymer science for the practicing surgeon J Craniofac...

32
438
0

Tài liệu Infectious Diseases of the Head and Neck pptx

Danh mục: Mỹ thuật

... Immunol 20 05 ; 23 :65 -67 22 0 Zerr DM Human herpesvirus 6: a clinical update Herpes 20 06; 13 :20 -24 22 1 Ward KN Human herpesviruses -6 and -7 infections Curr Opin Infect Dis 20 05;18 :24 7 -25 2 22 2 Clark DA ... et al Mycobacterial infections of the head and neck Otolaryngol Head Neck Surg 19 93; 109 (3 pt 1): 427 - 433 62 62 Am J Clin Pathol 20 07; 128 :35 -67 DOI: 10. 130 9/6BBT12WGNK77N4EH 40 Bayazit YA, Bayazit ... Head Neck 20 02; 24:597 -60 4 23 1 Sisk EA, Soltys SG, Zhu S, et al Human papillomavirus and p 53 mutational status as prognostic factors in head and neck carcinoma Head Neck 20 02; 24:841-849 23 2 Baez...

33
652
0

Báo cáo sinh học: "Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma" pot

Danh mục: Điện - Điện tử

... Median 61 .0 61 .0 Range 23 - 88 20 - 95 0. 866 60 .0 63 .1 20 - 95 41 - 81 0.140 61 61 24 - 95 20 - 88 66 (22 .3) 22 7 (77.7) 22 ( 23 .2) 0.9 72 73 ( 76. 8) Gender Male 21 7 (74 .3) 75 (25 .7) 66 (69 .5) 29 (30 .5) ... ( 86. 4) 0. 021 21 (7 .2) 82 ( 86. 3) 0.557 27 1 ( 92. 8) 0.0 52 ( 13 .6) (15 .3) 50 (84.7) 82 (22 .6) 28 1 (77.4) (31 .2) 11 (68 .8) 0 .34 5 0.150 0.8 56 0.541 0 .24 4 Lymph node metastasis2 0 .34 3 33 1 (91 .2) 32 (8.8) ... (months) Her2-/Her3- 26 2 36 . 0 1. 13 (0.87-1.47) 0 .3 42 Her2+/Her3- 91 51.0 0.70 (0.51-0.95) 0. 020 Her2-/Her3+ 21 25 .0 1. 53 (0.95 -2. 47) 0.074 Her2+/Her3+ 13 22 .0 1.48 (0.78 -2. 79) 0 .2 16 commonly characterized...

10
490
0

báo cáo hóa học:" Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma" doc

Danh mục: Hóa học - Dầu khí

... Median 61 .0 61 .0 Range 23 - 88 20 - 95 0. 866 60 .0 63 .1 20 - 95 41 - 81 0.140 61 61 24 - 95 20 - 88 66 (22 .3) 22 7 (77.7) 22 ( 23 .2) 0.9 72 73 ( 76. 8) Gender Male 21 7 (74 .3) 75 (25 .7) 66 (69 .5) 29 (30 .5) ... ( 86. 4) 0. 021 21 (7 .2) 82 ( 86. 3) 0.557 27 1 ( 92. 8) 0.0 52 ( 13 .6) (15 .3) 50 (84.7) 82 (22 .6) 28 1 (77.4) (31 .2) 11 (68 .8) 0 .34 5 0.150 0.8 56 0.541 0 .24 4 Lymph node metastasis2 0 .34 3 33 1 (91 .2) 32 (8.8) ... (months) Her2-/Her3- 26 2 36 . 0 1. 13 (0.87-1.47) 0 .3 42 Her2+/Her3- 91 51.0 0.70 (0.51-0.95) 0. 020 Her2-/Her3+ 21 25 .0 1. 53 (0.95 -2. 47) 0.074 Her2+/Her3+ 13 22 .0 1.48 (0.78 -2. 79) 0 .2 16 commonly characterized...

10
479
0

báo cáo hóa học:" Research Article Automatic Speech Recognition Systems for the Evaluation of Voice and Speech Disorders in Head and Neck Cancer" pdf

Danh mục: Hóa học - Dầu khí

... [10] [11] [ 12] [ 13] [14] [15] [ 16] [17] [18] [19] [20 ] [21 ] [22 ] [ 23 ] therapy of voice, speech, and language disorders,” Logopedics Phoniatrics Vocology, vol 34 , no 2, pp 91– 96, 20 09 G Van Nuﬀelen, ... Whitehill, and N Samman, “Consonant intelligibility and tongue motility in patients with partial glossectomy,” Journal of Oral and Maxillofacial Surgery, vol 62 , no 3, pp 29 8 30 3, 20 04 [4] H ... rater rater WR 0.9 0.88 0. 86 0.84 OC 0.84 0. 76 0.88 0. 82 — −0.90 LE 0. 82 0.84 0.77 0. 83 0.77 −0. 83 0. 82 0.8 0.78 0. 76 0.74 0-gram 1-gram 2- gram 3- gram Figure 2: Eﬀect of the language model context...

7
566
0

Pathology of the Head and Neck docx

Danh mục: Sức khỏe giới tính

... 21 8 21 9 22 0 22 0 22 0 22 0 22 1 22 2 22 2 22 2 22 3 22 3 22 4 22 4 22 4 22 4 22 5 22 5 8 .2. 2 .2 8 .2. 3 8 .2. 3. 1 8 .2. 3 .2 8 .2. 3. 3 8 .2. 3. 4 8 .2. 3. 5 8 .2. 3 .6 8 .2. 4 8 .2. 4.1 8 .2. 4 .2 8 .2. 4 .3 ... 84 84 3 .6 3 .6. 1 3 .6. 2 3 .6. 3 3 .6. 4 3 .6. 5 3 .6. 6 3 .6. 7 3 .6. 8 3 .6. 9 3. 7 3. 7.1 3. 7 .2 3. 7 .3 3.7.4 3. 7.5 3. 7 .6 3. 7 .6. 1 3. 7 .6. 2 3. 7 .6. 3 3.7 .6. 4 3. 7.7 3. 8 3. 8.1 3. 8 .2 3. 8 .2. 1 3. 8 .2. 2 3. 8 .2. 3 ... 6. 2. 7.1 Chordoma 6. 2. 7 .2 Sarcoma 6. 3 6. 3. 1 6. 3 .2 6. 3. 3 6. 3. 3.1 6. 3. 3 .2 6. 3. 4 6. 3. 4.1 6. 3. 4 .2 6. 3. 5 6. 3 .6 6 .3 .6. 1 6. 3 .6. 2 6. 3 .6. 3 6. 3 .6. 4 6. 3 .6. 5 6. 3. 7 Waldeyer’s...

334
336
1

Chapter 084. Head and Neck Cancer (Part 6) ppt

Danh mục: Sức khỏe giới tính

... of laryngeal cancer J Clin Oncol 24 : 36 9 3, 20 06 [PMID: 168 32 1 22] Seiwert TY et al: The chemoradiation paradigm in head and neck cancer Nat Clin Pract Oncol 4:145, 20 07 Slebos RJ et al: Gene expression ... advanced head and neck cancer N Engl J Med 35 0:1945, 20 04 [PMID: 15 128 894] Bonner JA et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 35 4: 567 , 20 06 [PMID: ... comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 : 92, 20 03 [PMID: 125 061 76] Bernier...

5
286
0

Báo cáo khoa học: " SemiCytokines levels, Severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer a prospective pilot study" ppt

Danh mục: Báo cáo khoa học

... week W3 = third treatment week W4 = fourth treatment week End = end of treatment 0% 66 .7% 33 .3% 66 .7% 42. 9% 0% 33 .3% 28 .6% 66 .7% 0% 0% 28 .6% 33 .3% 0% 0% Meirovitz et al Radiation Oncology 20 10, ... http://www.ro-journal.com/content/5/1/ 16 Page of Table Treatment modalities Parameter No of patients % No 11 73. 3 Yes 26 . 7 60 13. 3 66 13. 3 70 10 66 .7 72 6. 7 patients forced the use of two-tailed tests to evaluate ... Surgery Radiotherapy Total tumor dose, Gy RT Technique 2D 20 3D 10 66 .7 IMRT 13. 3 No 13 86. 7 Yes 13. 3 Yes (3 d, d, NOS) 20 No 12 80 46. 6 Parotid sparing RT interruptions Chemotherapy Neoadjuvant...

7
341
0

Báo cáo khoa học: "Use of kilovoltage X-ray volume imaging in patient dose calculation for head-and-neck and partial brain radiation therapy" pptx

Danh mục: Báo cáo khoa học

... mean dose 64 .9 64 .89 -0. 02% 2PTV: mean dose NPC (patient2) 47.14 1Whole body: max dose 63 . 76 63. 78 0. 03% 2Brain Stem: max dose 53. 83 54. 36 0.98% 2Spinal cord: max dose 32 . 85 32 . 73 -0 .34 % 2L-parotid: ... mean dose 34 . 92 34 .11 -2. 37 % 2R-parotid: mean dose 33 .38 32 . 91 -1.41% 2Whole body: max dose 70. 73 70. 12 0.87% 3CTV: mean dose 61 .85 61 .84 -0. 02% 3PTV: mean dose 60 .64 60 .57 -0.11% 3Brain: max ... -0. 26 % 2nd kV CBCT 50 .37 50.77 50. 76 32 . 56 28 . 73 51. 36 32 . 96 55.71 0.7% 0. 53% 0. 52% -1 .3% 5.81% 0. 86% 3. 77% -0.11% Dose difference between CBCT and kV CT(%) 2nd kV Dose comparison of the first and...

10
393
0